首页> 外国专利> METHOD FOR ASSESSING ABSORPTION FUNCTION OF SMALL INTESTINE

METHOD FOR ASSESSING ABSORPTION FUNCTION OF SMALL INTESTINE

机译:小肠吸收功能的评估方法

摘要

FIELD: medicine.;SUBSTANCE: method involves the nasoenteric administration of 99mTc-pertechnetate into a small intestine at 1.0-14 MBq/kg diluted with normal saline to an amount of 20 ml. That is immediately followed by a dynamic scintigraphy by means of two-detector rotation gamma-chamber for 60 minutes with a gamma-chamber detection mounted above a projection of the intestine and liver. Following the examination results enables calculated an absorption coefficient of a radiopharmaceutical agent (K); thereafter the scintigraphy is continued in the mode of "The Whole Body", which provides a basis to determine a percentage of the radiopharmaceutical agent (A) absorbed from an intestinal lumen. If the absorption coefficient is less than 3 and the absorption is less than 50% from the administered radiopharmaceutical agent, the small intestinal malabsorption is stated. K is described by the scintigram forming the sharpest image of the liver and having an area of interest 100 pxls to be marked within a liver, which is followed by constructing an activity/time curve. K is calculated as a slope of the curve to a horizontal axis with using the first 4 minutes of the linear rise of the curve by formula: K=(y2-y1)/(t2-t1)×60, wherein K is the absorption coefficient, t1 and t2 are time distances, seconds; y1 is a pulse count within the time distance t1, y2 is a pulse count within the time distance t2. To calculate A, an area including the whole patient's body and an area covering the visualised enteric loops are marked on the scintigram. The calculation follows the formula: A=(n(b)-n(e))/n(e)×100%, wherein n(b) is the total pulse count recorded within the whole body; n(e) is the total pulse count recorded within the small intestine.;EFFECT: method provides the high information value of the examination ensured by the complex analysis of the enteric function parameters in the early postoperative period.;3 cl, 3 dwg, 1 ex
机译:领域:药物;方法:该方法涉及将以浓水稀释至20 ml的1.0-14 MBq / kg的 99m Tc-高tech酸盐鼻肠给药。随后立即通过两个探测器旋转伽马腔进行60分钟的动态闪烁显像,并将伽马腔检测安装在肠和肝脏的投影上方。根据检查结果,可以计算出放射性药物(K)的吸收系数;此后,以“全身”模式继续闪烁显像,这为确定从肠腔吸收的放射性药物(A)的百分比提供了依据。如果从所施用的放射性药物吸收系数小于3并且吸收小于50%,则说明小肠吸收不良。 K通过闪烁图描述,该闪烁图形成了肝脏的最清晰图像,并在肝脏内标记了100 pxls的感兴趣区域,随后绘制了活动/时间曲线。使用曲线的线性上升的前4分钟,通过以下公式计算K为曲线相对于水平轴的斜率:K =(y 2 -y 1 )/(t 2 -t 1 )×60,其中K为吸收系数,t 1 和t 2 < / Sub>是时间距离,秒; y 1 是时间距离t 1 中的脉冲计数,y 2 是时间距离t 2 < / Sub>。为了计算A,在闪烁图上标记出包括整个患者身体的区域和覆盖可视化肠ic的区域。计算公式如下:A =(n(b)-n(e))/ n(e)×100%,其中n(b)是记录在全身的总脉冲数。 n(e)是小肠内记录的总脉搏计数。效果:该方法可通过术后早期肠功能参数的复杂分析确保检查具有较高的信息价值; 3 cl,3 dwg, 1前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号